2016 Pancreatic Cancer Workshop

The AGITG and the Australasian Pancreatic Club (APC) are hosting a Pancreas Cancer Research Workshop to be held in conjunction with the AGITG Annual Scientific Meeting. When: 2:00pm – 6:00pm, Tuesday 13th September 2016 Where: Sofitel Melbourne on Collins Registration: Free but seats are limited – click here Co-chairs Dr Lorraine … Read More

May 24, 2016

AGITG 2016 Annual General Meeting Report

The 2016 Annual General Meeting was held on Friday 13th May at Rydges Sydney International Airport Hotel.  The Notice of Meeting was circulated to members electronically on Tuesday 15th April. Financial Report Members voted by show of hands and by proxy to accept the 2015 Financial Report. Election of Board … Read More

May 18, 2016

ICECREAM Study Published in JCO

This phase ii, randomised, multi centre trial aims to provide important data on the optimal use of currently available therapeutics in patients with metastatic CRC, who have progressed on standard chemotherapy options. The trial is designed to study two questions in parallel. This first is to determine whether cetuximab is optimally … Read More

May 9, 2016

LAP07 study results published in JAMA

Compared with chemotherapy alone, chemoradiotherapy does not improve survival for patients with locally advanced pancreatic cancer, according to the LAP07 study published in the May 3 issue of the Journal of American Medical Association (JAMA). “I am pleased that this prestigious journal has recognised the LAP07 study results,” commented Professor … Read More

May 9, 2016

AGITG Trial News

The AGITG currently has six studies open to recruitment and nine studies in follow up. Please find following, a table indicating the trials which are still recruiting, and where the recruited patients numbers measure up against the trial target. Recruited Target ALT-GIST- GI Stromal Tumour 14 240 ASCOLT – Colorectal cancer 141 … Read More

May 5, 2016

4th Preceptorship in Colorectal Cancer – NOW OPEN

APPLICATIONS NOW OPEN  (Closes 20 May 2016) Dates: Friday 11th and Saturday 12th November 2016 Venue: The Como Hotel, 630 Chapel Street, South Yarra, VIC 3141 Attention: Senior Trainees and Junior Consultants Convenor: A/Prof Eva Segelov Preceptors: A/Prof Eva Segelov, Prof Stephen Clarke, A/Prof Peter Gibbs, Dr Chris Jackson, A/Prof Chris Karapetis … Read More

April 8, 2016

Calling for Nominations, John Zalcberg OAM Award

The John Zalcberg OAM Award for Excellence in AGITG Research recognises a member of the Australasian Gastro-Intestinal Trials Group (AGITG) who has made a significant and outstanding leadership contribution to AGITG research over a sustained period. Nominations may recognise the contributions of investigators, research staff and lay members of the … Read More

April 8, 2016

INTEGRATE II: A Randomised Phase III Double-Blind Placebo-Controlled Study of regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)

Building on the success of the INTEGRATE trial that was presented at ASCO in 2015. INTEGRATE showed that participants with AGOC treated with regorafenib experienced a longer period where their cancer did not grow, and that the drug was no more toxic in participants with AGOC than in patients with … Read More

April 8, 2016

Innovation Fund applications are now open!

Applications are now open for the AGITG Innovation Fund, made possible by the generosity of charitable donations raised through the GI Cancer Institute Gutsy Challenge. Annual grants from this fund of up to $50,000 per year over 1-2 years are intended to encourage leadership in design and conduct of investigator-initiated … Read More

March 8, 2016

EOI for ASM Study Coordinators Forum

Study Coordinators involved in AGITG studies are invited to consider joining the AGITG 18th Annual Scientific Meeting Study Coordinators Forum Planning Committee (the ’Committee’).  The Forum is a highly successful and integral component of the AGITG Annual Scientific Meeting program. The primary roles of the Committee are to plan and … Read More

February 28, 2016